Synopsis of recent research by authors named "Kezhen L Tang"
- Kezhen L Tang's research primarily focuses on the assessment of patient-reported outcomes and satisfaction regarding various biologic treatments for inflammatory arthritis and inflammatory bowel disease (IBD).
- Significant findings include the evaluation of subcutaneous golimumab's efficacy and patient satisfaction among rheumatoid arthritis patients, showing improved treatment experiences compared to previous therapies.
- Additionally, studies highlighted the safety profile of infliximab in pediatric IBD patients, demonstrating no increased risk of malignancy, which contributes to understanding long-term treatment responses and safety in vulnerable populations.
